Could Tavapadon Change Parkinson's Care?

Details werden geladen...

Could Tavapadon Change Parkinson's Care?

If approved by the FDA, tavapadon would be the first new dopamine agonist for Parkinson's disease in decades. What does the research show about efficacy and safety?

FDA Approves Stelara for Pediatric Ulcerative Colitis

FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients | The Manila Times

U.S. FDA Grants Priority Review to Agios’ sNDA for Mitapivat in Sickle Cell Disease | The Manila Times

4TEEN4 Receives U.S. FDA Fast Track Designation for Invobenitug in Cardiogenic Shock | The Manila Times

Registrieren

Could Tavapadon Change Parkinson's Care?

FDA Approves Stelara for Pediatric Ulcerative Colitis

FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients | The Manila Times

U.S. FDA Grants Priority Review to Agios’ sNDA for Mitapivat in Sickle Cell Disease | The Manila Times

4TEEN4 Receives U.S. FDA Fast Track Designation for Invobenitug in Cardiogenic Shock | The Manila Times